| ASSET | YEAR | % RETURN |
|---|---|---|
Neurocrine Biosciences (NBIX) | 2010 | 175.81% |
Neurocrine Biosciences (NBIX) | 2011 | 10.1% |
Neurocrine Biosciences (NBIX) | 2012 | -14.42% |
Neurocrine Biosciences (NBIX) | 2013 | 21.61% |
Neurocrine Biosciences (NBIX) | 2014 | 140.99% |
Neurocrine Biosciences (NBIX) | 2015 | 150.42% |
Neurocrine Biosciences (NBIX) | 2016 | -30.02% |
Neurocrine Biosciences (NBIX) | 2017 | 100.03% |
Neurocrine Biosciences (NBIX) | 2018 | -7.89% |
Neurocrine Biosciences (NBIX) | 2019 | 53.03% |
Neurocrine Biosciences (NBIX) | 2020 | -11.25% |
Neurocrine Biosciences (NBIX) | 2021 | -10.65% |
Neurocrine Biosciences (NBIX) | 2022 | 39.05% |
Neurocrine Biosciences (NBIX) | 2023 | 10.47% |
Neurocrine Biosciences (NBIX) | 2024 | 4.84% |
Neurocrine Biosciences (NBIX) | 2025 | -2.87% |
